Post Traumatic Stress Disorder
403
80
90
192
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
58 trials with published results (14%)
Research Maturity
192 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.7%
19 terminated out of 403 trials
91.0%
+4.5% vs benchmark
4%
18 trials in Phase 3/4
30%
58 of 192 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 192 completed trials
Clinical Trials (403)
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
MDMA Therapy in Veterans With PTSD
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Fear and Avoidance in PTSD Patients
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Psychotherapy Effects on Reward Processing in PTSD
Predictive Value of Early Peritraumatic Distress Screening for Childbirth-PTSD Following Unplanned Cesarean Delivery
Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD)
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
A Study to Assess the Use of Methylone in the Treatment of PTSD
MDMA-Assisted Massed Exposure Therapy for PTSD
Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder
Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy
Evaluation of a Trauma-Informed Partner Violence Intervention Program
Alexithymia Intervention for Suicide
Probiotic (LGG) for Veterans With PTSD
Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD